Federation Des Caisses Desjardins Du Quebec Aerie Pharmaceuticals Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Aug 30, 2024
SELL
$17.72 - $25.1 $17,720 - $25,100
-1,000 Closed
0 $0
Q3 2019

Aug 30, 2024
BUY
$18.41 - $28.0 $18,410 - $28,000
1,000 New
1,000 $19.2 Million
Q2 2018

Aug 30, 2024
SELL
$47.85 - $70.45 $33,495 - $49,315
-700 Closed
0 $0
Q1 2018

Aug 30, 2024
SELL
$51.15 - $61.0 $23,017 - $27,450
-450 Reduced 39.13%
700 $38 Million
Q4 2017

Aug 30, 2024
BUY
$50.85 - $65.1 $58,477 - $74,865
1,150
1,150 $68.7 Million

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email